Komori
Share Issuance and Disposal4586Medrx Co.,Ltd.Pharmaceuticals

Notice Concerning the Large-Scale Exercise of the 35th Series Stock Acquisition Rights Issued Through a Third-Party Allotment (With Exercise Price Adjustment Clause)

Between 1 August 2026 and 14 August 2026, 15,222 of the 35th Series of Stock Acquisition Rights were exercised, and 1,522,200 new shares were delivered. As a result, the number of unexercised stock acquisition rights decreased from 79,395 to 64,173.

Worth reading
69In focus
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
10.3
Exercise ratio to total number issued (%)
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Large-scale exercise of the 35th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)

Who receives how much

1,522,200 new shares (0 treasury shares transferred)

グロース・キャピタル株式会社 (allottee of the 35th Series of Stock Acquisition Rights)

The lower thin line represents the existing number of shares to which these shares will be added.

Terms of the stock acquisition rights
Exercise price
¥61 or ¥62. The exercise price is subject to adjustment, but the adjustment floor is not disclosed
Number of Stock Acquisition Rights
Total issued: 147,820; currently unexercised: 64,173 (6,417,300 shares)
Most recent equity financing
5 June 2026: Issuance of the 35th Stock Acquisition Rights (with Exercise Price Adjustment Clause), with Growth Capital Co., Ltd. as the allottee (total issued: 147,820)
Details of issuance or disposal
ItemDetails
Type of issuance or disposalLarge-scale exercise of the 35th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)
Number of shares to be issued or disposed of1,522,200 new shares (0 treasury shares transferred)
Intended allotteeグロース・キャピタル株式会社 (allottee of the 35th Series of Stock Acquisition Rights)
Total number of issued shares66,207,600 shares (including 2 treasury shares, as of the end of the month preceding the target month) → Not disclosed
Exercise price¥61 or ¥62. The exercise price is subject to adjustment, but the adjustment floor is not disclosed
Number of Stock Acquisition RightsTotal issued: 147,820; currently unexercised: 64,173 (6,417,300 shares)
Most recent equity financing5 June 2026: Issuance of the 35th Stock Acquisition Rights (with Exercise Price Adjustment Clause), with Growth Capital Co., Ltd. as the allottee (total issued: 147,820)
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The exercise status is being disclosed because a large volume of these stock acquisition rights was exercised.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning the Large-Scale Exercise of the 35th Series Stock Acquisition Rights Issued Through a Third-Party Allotment (With Exercise Price Adjustment Clause) | Medrx Co.,Ltd. (4586) timely disclosure | Komori